Hepatitis C virus infections in the Democratic Republic of Congo exhibit a cohort effect

James C Iles, GL Abby Harrison, Sinead Lyons, Cyrille F Djoko, Ubald Tamoufe, Matthew Lebreton, Bradley S Schneider, Joseph N Fair, Felix M Tshala, Patrick K Kayembe, Jean Jacques Muyembe, Samuel Edidi-Basepeo, Nathan D Wolfe, Paul Klenerman, Peter Simmonds, Oliver G Pybus
2013-10-01
Abstract:The prevalence and genetic diversity of hepatitis C virus (HCV) and human pegivirus (HPgV) in many regions of sub-Saharan Africa is poorly characterized, including in the Democratic Republic of Congo – the largest country in the region and one of the most populous. To address this situation we conducted a molecular epidemiological survey of HCV and HPgV (previously named GB Virus C or hepatitis G virus) in samples collected in 2007 from 299 males from the DRC, whose ages ranged from 21 to 71 years old. Samples were tested for the presence of HCV antibodies by ELISA and reactive samples were subsequently tested for HCV RNA using RT-PCR in which both the HCV Core and NS5B genome regions were amplified. Remaining samples were tested for HPgV RNA and the HPgV NS3 genome region of positive samples was amplified. For HCV, 13.7% of the samples were seropositive (41/299) but only …
What problem does this paper attempt to address?